These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7083021)

  • 1. Apomorphine increases the activity of rat globus pallidus neurons.
    Bergstrom DA; Bromley SD; Walters JR
    Brain Res; 1982 Apr; 238(1):266-71. PubMed ID: 7083021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurophysiological evidence that D-1 dopamine receptor blockade attenuates postsynaptic but not autoreceptor-mediated effects of dopamine agonists.
    Carlson JH; Bergstrom DA; Walters JR
    Eur J Pharmacol; 1986 Apr; 123(2):237-51. PubMed ID: 2940101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of interruption of the nigrostriatal pathway and of dopaminergic agents on the spontaneous activity of globus pallidus neurons in the awake monkey.
    Filion M
    Brain Res; 1979 Dec; 178(2-3):425-41. PubMed ID: 116713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Action of systemic apomorphine on dopamine cell firing after neostriatal kainic acid lesion.
    Baring MD; Walters JR; Eng N
    Brain Res; 1980 Jan; 181(1):214-8. PubMed ID: 7350957
    [No Abstract]   [Full Text] [Related]  

  • 5. Nigrostriatal lesion alters neurophysiological responses to selective and nonselective D-1 and D-2 dopamine agonists in rat globus pallidus.
    Carlson JH; Bergstrom DA; Demo SD; Walters JR
    Synapse; 1990; 5(2):83-93. PubMed ID: 2309160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrapallidal injection of 6-hydroxydopamine induced changes in dopamine innervation and neuronal activity of globus pallidus.
    Bouali-Benazzouz R; Tai CH; Chetrit J; Benazzouz A
    Neuroscience; 2009 Dec; 164(2):588-96. PubMed ID: 19628021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for NMDA/D2 receptor-receptor interactions in the rat striatum.
    Micheletti G; Lannes B; Warter JM; Zwiller J
    Adv Neurol; 1993; 60():128-32. PubMed ID: 8380517
    [No Abstract]   [Full Text] [Related]  

  • 8. Single unit responses of substantia nigra pars reticulata neurons to apomorphine: effects of striatal lesions and anesthesia.
    Waszczak BL; Lee EK; Ferraro T; Hare TA; Walters JR
    Brain Res; 1984 Jul; 306(1-2):307-18. PubMed ID: 6466980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiological and behavioral assessments of dopamine autoreceptor activation to apomorphine in rats.
    Okuyama S; Shimamura H; Hashimoto S; Aihara H
    Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):246-54. PubMed ID: 3827410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low doses of apomorphine elicit two opposing influences on dopamine cell electrophysiology.
    Grace AA; Bunney BS
    Brain Res; 1985 May; 333(2):285-98. PubMed ID: 3995296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haloperidol-induced disruption of retrieval behavior and reversal with apomorphine in lactating rats.
    Giordano AL; Johnson AE; Rosenblatt JS
    Physiol Behav; 1990 Jul; 48(1):211-4. PubMed ID: 2236274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The response of non-dopamine neurons in substantia nigra and ventral tegmental area to amphetamine and apomorphine during hypermotility: the striatal influence.
    Olds ME
    Brain Res; 1988 Jun; 452(1-2):237-54. PubMed ID: 3401732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of depolarization block in midbrain dopamine neurons by repeated administration of haloperidol: analysis using in vivo intracellular recording.
    Grace AA; Bunney BS
    J Pharmacol Exp Ther; 1986 Sep; 238(3):1092-100. PubMed ID: 3746660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diminished responses of nigral dopaminergic neurons to haloperidol and morphine following lesions in the striatum.
    Kondo Y; Iwatsubo K
    Brain Res; 1980 Jan; 181(1):237-40. PubMed ID: 7350960
    [No Abstract]   [Full Text] [Related]  

  • 15. SCH23390 effects on apomorphine-induced responses of nigral dopaminergic neurons.
    Napier TC; Givens BS; Schulz DW; Bunney BS; Breese GR; Mailman RB
    J Pharmacol Exp Ther; 1986 Mar; 236(3):838-45. PubMed ID: 3512819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time schedule of apomorphine administration determines the degree of globus pallidus excitation.
    Bergstrom DA; Bromley SD; Walters JR
    Eur J Pharmacol; 1982 Feb; 78(2):245-8. PubMed ID: 7075674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential electrophysiological effects of 3-PPP and its enantiomers on dopamine autoreceptors and postsynaptic receptors.
    Bergstrom DA; Carlson JH; Bromley SD; Jackson DM; Walters JR
    Eur J Pharmacol; 1986 May; 124(1-2):75-84. PubMed ID: 3720847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-n-propyl-norapomorphine: an extremely potent stimulant of dopamine autoreceptors.
    Argiolas A; Mereu G; Serra G; Melis MR; Fadda F; Gessa GL
    Brain Res; 1982 Jan; 231(1):109-16. PubMed ID: 6799148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haloperidol-induced alteration of post-firing inhibition in dopaminergic neurons of rat substantia nigra.
    Wilson CJ; Fenster GA; Young SJ; Groves PM
    Brain Res; 1979 Dec; 179(1):165-70. PubMed ID: 509227
    [No Abstract]   [Full Text] [Related]  

  • 20. Responsiveness of nigral neurons to the stimulation of striatal dopaminergic receptors in the rat.
    Scarnati E; Forchetti C; Ciancarelli G; Pacitti C; Agnoli A
    Life Sci; 1980 Apr; 26(15):1203-9. PubMed ID: 7392796
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.